370860-76-7Relevant academic research and scientific papers
Cyclohexylamine derivative as subtype selective nmda receptor antagonists
-
Page 11, (2010/02/06)
Described are compounds of Formula I and Formula II and their pharmaceutically acceptable salts. The compounds of Formulas I and II are antagonists of NMDA receptor channel complexes useful for treating cerebral vascular disorders such as, for example, cerebral ischemia, cardiac arrest, stroke, and Parkinson's disease.
